RTP drug developer adds $30M to extend cash runway


A drug developer in Research Triangle Park has extended its cash runway as it moves multiple clinical programs forward.

Previous American Financial makes $240 million acquisition of Crop Risk Insurance
Next USAA posts first loss in 100 years; blames inflation, weak markets